Rare diseases
Investigational molecules
Locations
Back to Spain71 clinical trials in Sant Cugat Del Valles, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of BMS-986446 for Early Alzheimer's Disease Patients
SpainStudy Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
SpainStudy on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration
SpainStudy on Elamipretide for Patients with Dry Age-Related Macular Degeneration (Dry AMD)
SpainStudy on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson's Disease
SpainStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
SpainSafety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby
SpainStudy on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer
SpainStudy on Bepranemab for Patients with Early Alzheimer's Disease
SpainStudy on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome
SpainStudy of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup
SpainStudy on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Parkinson's Disease treatments, including multiple trials evaluating new therapeutic approaches. Studies are investigating novel compounds like tavapadon and BIIB122 for improved symptom management.
Innovative trials targeting Age-Related Macular Degeneration and its complications, particularly Geographic Atrophy. Research includes both intravitreal treatments and systemic approaches to manage disease progression.
Comprehensive research in breast cancer treatments, particularly focusing on HER2-positive and hormone receptor-positive variants. Studies evaluate new targeted therapies and combination treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
